565 related articles for article (PubMed ID: 8535913)
1. Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study.
Achiron R; Lipitz S; Sivan E; Goldenberg M; Horovitz A; Frenkel Y; Mashiach S
Ultrasound Obstet Gynecol; 1995 Aug; 6(2):116-20. PubMed ID: 8535913
[TBL] [Abstract][Full Text] [Related]
2. Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: an ultrasound, color flow Doppler, hysteroscopic and histological study.
Exacoustos C; Zupi E; Cangi B; Chiaretti M; Arduini D; Romanini C
Ultrasound Obstet Gynecol; 1995 Dec; 6(6):435-42. PubMed ID: 8903921
[TBL] [Abstract][Full Text] [Related]
3. Endometrial blood flow response to estrogen replacement therapy and tamoxifen in asymptomatic, postmenopausal women: a transvaginal Doppler study.
Achiron R; Lipitz S; Frenkel Y; Mashiach S
Ultrasound Obstet Gynecol; 1995 Jun; 5(6):411-4. PubMed ID: 7552804
[TBL] [Abstract][Full Text] [Related]
4. Transvaginal sonographic and hysteroscopic findings in postmenopausal women receiving tamoxifen.
Marconi D; Exacoustos C; Cangi B; Perroni A; Zupi E; Valli E; Romanini C
J Am Assoc Gynecol Laparosc; 1997 May; 4(3):331-9. PubMed ID: 9154782
[TBL] [Abstract][Full Text] [Related]
5. The endometrium in asymptomatic breast cancer patients on tamoxifen: value of transvaginal ultrasonography with saline infusion and Doppler flow.
Develioğlu OH; Omak M; Bilgin T; Esmer A; Tüfekçi M
Gynecol Oncol; 2004 May; 93(2):328-35. PubMed ID: 15099941
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
[TBL] [Abstract][Full Text] [Related]
7. Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings.
Hann LE; Giess CS; Bach AM; Tao Y; Baum HJ; Barakat RR
AJR Am J Roentgenol; 1997 Mar; 168(3):657-61. PubMed ID: 9057510
[TBL] [Abstract][Full Text] [Related]
8. Transvaginal endometrial sonography in postmenopausal women taking tamoxifen.
Tesoro MR; Borgida AF; MacLaurin NA; Asuncion CM
Obstet Gynecol; 1999 Mar; 93(3):363-6. PubMed ID: 10074980
[TBL] [Abstract][Full Text] [Related]
9. Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen.
Mourits MJ; Van der Zee AG; Willemse PH; Ten Hoor KA; Hollema H; De Vries EG
Gynecol Oncol; 1999 Apr; 73(1):21-6. PubMed ID: 10094875
[TBL] [Abstract][Full Text] [Related]
10. [Changes in the endometrium in treatment of breast carcinoma with tamoxifen].
Reslová T; Tosner J; Vávrová I; Resl M
Ceska Gynekol; 1997 Oct; 62(5):277-9. PubMed ID: 9600168
[TBL] [Abstract][Full Text] [Related]
11. Sonohysterography for ultrasonographic evaluation of tamoxifen-associated cystic thickened endometrium.
Achiron R; Lipitz S; Sivan E; Goldenberg M; Mashiach S
J Ultrasound Med; 1995 Sep; 14(9):685-8. PubMed ID: 7500435
[TBL] [Abstract][Full Text] [Related]
12. [The progesterone test and transvaginal sonography as methods for the early discovery and screening of endometrial cancer in women in the postmenopause from some risk groups].
Ivanov S; Ivanov S
Akush Ginekol (Sofiia); 1999; 38(2):29-30. PubMed ID: 10730382
[TBL] [Abstract][Full Text] [Related]
13. Prospective longitudinal study of ultrasound screening for endometrial abnormalities in women with breast cancer receiving tamoxifen.
Fung MF; Reid A; Faught W; Le T; Chenier C; Verma S; Brydon E; Fung KF
Gynecol Oncol; 2003 Oct; 91(1):154-9. PubMed ID: 14529676
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of transvaginal ultrasonographic and diagnostic hysteroscopic findings in postmenopausal breast cancer patients treated with tamoxifen.
Gao WL; Zhang LP; Feng LM
Chin Med J (Engl); 2011 Aug; 124(15):2335-9. PubMed ID: 21933565
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen and the uterus: an old drug tested by new modalities.
Achiron R; Grisaru D; Golan-Porat N; Lipitz S
Ultrasound Obstet Gynecol; 1996 May; 7(5):374-8. PubMed ID: 8774108
[TBL] [Abstract][Full Text] [Related]
16. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR
J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
[TBL] [Abstract][Full Text] [Related]
17. Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology.
Gerber B; Krause A; Reimer T; Mylonas I; Makovitzky J; Kundt G; Janni W
Clin Cancer Res; 2006 Feb; 12(4):1245-50. PubMed ID: 16489080
[TBL] [Abstract][Full Text] [Related]
18. Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound.
Gerber B; Krause A; Müller H; Reimer T; Külz T; Makovitzky J; Kundt G; Friese K
J Clin Oncol; 2000 Oct; 18(20):3464-70. PubMed ID: 11032586
[TBL] [Abstract][Full Text] [Related]
19. The effect of tamoxifen on the endometrium, serum lipids and hypothalamus pituitary axis in the postmenopausal breast cancer patients.
Kavak ZN; Binöz S; Ceyhan N; Pekin S
Acta Obstet Gynecol Scand; 2000 Jul; 79(7):604-7. PubMed ID: 10929963
[TBL] [Abstract][Full Text] [Related]
20. Abnormalities detected on transvaginal ultrasonography in tamoxifen-treated postmenopausal breast cancer patients may represent endometrial cystic atrophy.
McGonigle KF; Shaw SL; Vasilev SA; Odom-Maryon T; Roy S; Simpson JF
Am J Obstet Gynecol; 1998 Jun; 178(6):1145-50. PubMed ID: 9662294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]